U.S. Pharma Stock News

Context for DoorDash’s Recent Share Performance DoorDash (DASH) has drawn attention after a series of recent share declines, including about 9% over the past month and 25% over the past 3 months, prompting closer scrutiny of its latest fundamentals. See our latest analysis for DoorDash. At a share price of $169.48, DoorDash’s recent 1 month share price return of 9% and year to date share price return of 22.89% sit against a 1 year total shareholder return of 9.71% and a very large 3 year...

With no single headline event driving attention, Booking Holdings (BKNG) is on investor radars as its recent share performance contrasts with solid annual revenue and net income figures. This raises questions about how the market is currently pricing the business. See our latest analysis for Booking Holdings. At a share price of US$4,322.42, Booking Holdings has recently seen a 2.01% 30 day share price return but an 18.80% year to date share price decline, while its 3 year total shareholder...

In early March 2026, Cardinal Health announced that longtime Senior Vice President and Chief Accounting Officer Mary Scherer plans to retire in February 2027, and the company has begun searching for her successor while she stays on to oversee an orderly transition. This carefully staged leadership change in a core finance role comes as Cardinal Health is emphasizing earnings growth, acquisitions and product innovation as key elements of its longer-term plans. Next, we’ll examine how Cardinal...

Rivian Automotive (NasdaqGS:RIVN) spin out Mind Robotics has raised $500 million in Series A funding. The round establishes Mind Robotics as a new industrial robotics player with Rivian as a partner and major shareholder. Rivian’s CEO is involved with the new company, signaling potential collaboration around factory automation and manufacturing technology. Rivian is best known for its electric trucks, SUVs, and commercial vans. This Mind Robotics transaction adds another dimension to its...

Element Solutions recently faced a sector-driven setback as escalating conflict in the Middle East pushed up crude oil and petrochemical feedstock costs, prompting investors to reassess cost pressures across specialty chemical producers. The reaction appears tied more to short-term fears about margin compression from higher inputs than to any shift in Element Solutions’ underlying demand or operations, which remain unchanged. We’ll now examine how concerns over rising input costs and...

Elevance Health (NYSE:ELV) has signed new network participation agreements with Myomo, Inc. The deals extend in-network coverage for Myomo’s FDA cleared orthopedic devices to Elevance’s roughly 45 million Commercial, Medicare Advantage, and Medicaid members nationwide. For you as an investor, this ties directly into how NYSE:ELV positions itself as a broad based health benefits and services company. Elevance already spans commercial employer plans, government programs, and related health...

Texas Pacific Land (TPL) is back on investors’ radar after the company increased its quarterly dividend to US$0.60 per share and reported strong fourth quarter earnings, supported by its Water Services and Land segments. See our latest analysis for Texas Pacific Land. The share price has moved sharply in recent months, with a 40.14% 1 month share price return and a 76.85% 3 month share price return. The 1 year total shareholder return of 17.53% and 3 year total shareholder return of about 3x...

On 11 March 2026, SprintRay announced the launch of its Midas World Tour, a collaboration with Align Technology, GC America and Meisinger Dental to promote an integrated, same-day digital restorative workflow that combines iTero scanning, AI-driven 3D printing, advanced materials and finishing tools. This partnership highlights how Align’s iTero scanners are becoming a core part of chairside restorative dentistry as 3D printing moves toward an integrated workflow standard in dental...

Context for UiPath after recent share moves UiPath (PATH) has seen its share price move sharply in recent trading, with a 6.8% gain over the past day and 11.8% over the past week, even as returns over the past month and past 3 months remain negative. That mix of short term strength alongside weaker recent performance is prompting some investors to reassess how the company’s US$1,553.1m in annual revenue and US$229.7m in net income line up against current market expectations for the automation...

Earlier this week, Citigroup’s Ariel Rosa shifted Schneider National’s rating from “Sell” to “Neutral,” citing mixed financial indicators, earnings volatility, and broad sector headwinds, while acknowledging the company’s diversified operations across truckload and intermodal freight. This change in analyst stance, following a period of subdued revenue growth and falling earnings per share, spotlights how Schneider’s business mix and perceived earnings reliability are becoming central to how...

Cisco Systems (CSCO) has come under pressure after its latest earnings, as concerns about lower gross margins, rising memory costs, and a hardware heavy mix outweighed solid order growth and headline beats. See our latest analysis for Cisco Systems. The share price reaction around earnings fits into a mixed pattern, with a 10% 30 day share price decline and a 3.4% 7 day pullback, offset by a stronger 32.3% 1 year total shareholder return. This suggests that shorter term momentum is fading...

Global Business Travel Group (NYSE:GBTG) has completed its acquisition of CWT, reaching what management calls an inflection point in its business transformation. The company is rolling out Egencia AI, which management says is already contributing to measurable revenue and cost efficiencies. GBTG reports strong revenue growth and profitability in 2025 alongside accelerated integration, restructuring, and productivity efforts. For investors watching NYSE:GBTG, the share price at $5.57 sits...

Recent commentary from Barclays on Jazz Pharmaceuticals (JAZZ) has put fresh attention on the stock, after the bank highlighted the durability of its central nervous system therapies and record fourth quarter revenue tied to Xywav, Epidiolex, and Modeyso. See our latest analysis for Jazz Pharmaceuticals. At a share price of US$185.43, Jazz has given investors a 12.38% 1 month share price return and a 38.22% 1 year total shareholder return. This suggests that recent revenue headlines and...

What is driving Cipher Digital’s recent stock volatility? Cipher Digital (CIFR) is in focus after shifting its business toward high performance computing and AI infrastructure, supported by partnerships with large tech firms, asset sales, and fresh acquisitions. This repositioning, combined with elevated short interest and mixed analyst views, has contributed to the recent volatility that investors are now trying to interpret. See our latest analysis for Cipher Digital. At a share price of...

Transocean has completed an all stock acquisition of Valaris, combining two major offshore drilling companies. The deal significantly expands Transocean's offshore rig fleet and contract portfolio. Management expects cost synergies and a stronger competitive position in the global offshore drilling market. For investors watching NYSE:RIG, this merger follows a period of strong share price moves, with the stock up 48.8% year to date and 111.7% over the past year, closing at $6.31. The...

If you are wondering whether Preformed Line Products is still offering value after a strong run, this article walks through what the current share price might be implying about the business. The stock closed at US$267.23 recently, with returns of 4.6% over 7 days, a 2.5% decline over 30 days, 26.1% year to date and 118.3% over the past year, as well as 135.3% over 3 years and 271.3% over 5 years. Recent attention on grid reliability, utility infrastructure and related capital projects has...

If you are wondering whether Domino's Pizza shares are priced attractively today, the key question is how the current market price compares with the company's underlying value. The stock recently closed at US$393.29, with returns of a 3.3% decline over 7 days, 0.3% over 30 days, a 7.5% decline year to date and an 8.9% decline over the past year, while the 3 year and 5 year returns sit at 30.8% and 15.0% respectively. Recent company news has focused on Domino's ongoing efforts to refine its...

Wells Fargo has filed a trademark application for "WFUSD," indicating potential plans to offer digital asset and cryptocurrency services. The filing points to possible products such as crypto trading, exchange services, payment processing, and digital asset wallets. This move would represent an expansion of Wells Fargo's role in the growing crypto and blockchain segment of financial services. Shares of Wells Fargo (NYSE:WFC) last closed at $76.88, with the stock showing a 14.0% return over...

Lantronix (LTRX) is back on investor radars after expanding its embedded compute portfolio with new MediaTek based System on Module solutions and signing a European distribution deal with Melchioni Electronics. See our latest analysis for Lantronix. The recent MediaTek based SOM launch and the Melchioni distribution deal arrive after a mixed stretch for the stock, with a 7 day share price return of 3.89% but a 90 day share price return decline of 6.69%, while the 1 year total shareholder...

uniQure (NasdaqGS:QURE) faces multiple securities class action lawsuits focused on disclosures around its AMT-130 gene therapy program. Federal health officials have criticized the company for alleged data manipulation tied to AMT-130. The FDA has withdrawn support for a Biologics License Application for AMT-130, complicating the program's regulatory path. Upcoming changes in FDA leadership are expected to affect how AMT-130 and related filings are reviewed. These developments arrive at a...

If you are wondering whether Viavi Solutions is still fairly priced after a big run, this breakdown will help you see how the current share price stacks up against several valuation yardsticks. The stock last closed at US$30.09, with returns of 8.9% over the past 30 days and 65.8% year to date, while the 1 year return sits at 179.6% and the 3 year return at 193.3%. Over the past year, Viavi Solutions has been in the news for its position in optical networking and communications testing. This...

CrowdStrike Holdings (NasdaqGS:CRWD) announced a new partnership with Perplexity to bring its Falcon platform into Perplexity’s Comet Enterprise product. The collaboration focuses on browser-layer security for AI-powered enterprise workflows and AI-native browsing. The deal uses technology from CrowdStrike’s Seraphic acquisition to address web threats and unmanaged devices. CrowdStrike is best known for its Falcon cybersecurity platform, which targets endpoint, cloud, and identity threats...

If you are wondering whether Amdocs is starting to look like value after a weaker share price, this article will help you weigh what the current price actually offers you. The stock last closed at US$66.92, with returns of a 2.6% decline over 7 days, an 8.8% decline over 30 days, a 16.5% decline year to date, and a 21.6% decline over the past year. Recent coverage around Amdocs has focused on its role as a software and services provider to telecom and media companies. This keeps attention on...

Servier Pharmaceuticals has entered into a definitive agreement to acquire Day One Biopharmaceuticals, NasdaqGS:DAWN, in an all cash transaction. The deal marks a material change in ownership, bringing Day One Biopharmaceuticals under Servier control and ending its status as an independent company once the transaction closes. Day One Biopharmaceuticals focuses on developing and commercializing oncology therapies, a segment that has seen frequent partnerships, licensing arrangements, and...